Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marian A Ackun-Farmmer

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Advanced Nanobiomed Research|March 20, 2023
Delivery route considerations for designing antigen-specific biomaterial strategies to combat autoimmunityMarian A Ackun-Farmmer, Christopher M Jewell
Advanced Biosystems|October 19, 2020
Ligand Density Controls C-Type Lectin-Like Molecule-1 Receptor-Specific Uptake of Polymer NanoparticlesMarian A Ackun-Farmmer, Kharimat L Alatise, Griffin Cross, et al.
Journal of Biomedical Materials Research. Part A|July 28, 2021
Macrophage depletion increases target specificity of bone-targeted nanoparticlesMarian A Ackun-Farmmer, Baixue Xiao, Maureen R Newman, et al.
Chemistry of Materials : a Publication of the American Chemical Society|May 23, 2025
Synthetic organic materials for targeting immunotherapies to lymph nodesChristopher J Bridgeman, Ruochen Shen, Ryan A McIlvaine, et al.
Current Opinion in Biomedical Engineering|August 30, 2021
Biomaterials for Orthopaedic Diagnostics and TheranosticsMarian A Ackun-Farmmer, Clyde T Overby, Brittany E Haws, et al.
ACS Biomaterials Science & Engineering|March 27, 2024
Advancing Bone-Targeted Drug Delivery: Leveraging Biological Factors and Nanoparticle Designs to Improve Therapeutic EfficacyBaixue Xiao, Marian A Ackun-Farmmer, Emmanuela Adjei-Sowah, et al.
Advanced Therapeutics|January 31, 2022
Nanoparticle-Mediated Delivery of Micheliolide Analogs to Eliminate Leukemic Stem Cells in the Bone MarrowMarian A Ackun-Farmmer, Hanan Alwaseem, Michele Counts, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 16, 2021
Reduction of leukemic burden via bone-targeted nanoparticle delivery of an inhibitor of C-chemokine (C-C motif) ligand 3 (CCL3) signalingMarian A Ackun-Farmmer, Celia A Soto, Maggie L Lesch, et al.
ACS Nano|November 9, 2024
Engineered Immune Constructs Alter Antigen-Specific Immune Tolerance and Confer Durable Protection in Myelin-Driven AutoimmunityMarian A Ackun-Farmmer, Marina Willson Shirkey, Robert S Oakes, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2025
Local control of T cell fate in lymph nodes safely and durably reverses myelin-driven autoimmunitySenta M Kapnick, Emily A Gosselin, Shannon J Tsai, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Advanced Nanobiomed Research|March 20, 2023
Delivery route considerations for designing antigen-specific biomaterial strategies to combat autoimmunityMarian A Ackun-Farmmer, Christopher M Jewell
Advanced Biosystems|October 19, 2020
Ligand Density Controls C-Type Lectin-Like Molecule-1 Receptor-Specific Uptake of Polymer NanoparticlesMarian A Ackun-Farmmer, Kharimat L Alatise, Griffin Cross, et al.
Journal of Biomedical Materials Research. Part A|July 28, 2021
Macrophage depletion increases target specificity of bone-targeted nanoparticlesMarian A Ackun-Farmmer, Baixue Xiao, Maureen R Newman, et al.
Chemistry of Materials : a Publication of the American Chemical Society|May 23, 2025
Synthetic organic materials for targeting immunotherapies to lymph nodesChristopher J Bridgeman, Ruochen Shen, Ryan A McIlvaine, et al.
Current Opinion in Biomedical Engineering|August 30, 2021
Biomaterials for Orthopaedic Diagnostics and TheranosticsMarian A Ackun-Farmmer, Clyde T Overby, Brittany E Haws, et al.
ACS Biomaterials Science & Engineering|March 27, 2024
Advancing Bone-Targeted Drug Delivery: Leveraging Biological Factors and Nanoparticle Designs to Improve Therapeutic EfficacyBaixue Xiao, Marian A Ackun-Farmmer, Emmanuela Adjei-Sowah, et al.
Advanced Therapeutics|January 31, 2022
Nanoparticle-Mediated Delivery of Micheliolide Analogs to Eliminate Leukemic Stem Cells in the Bone MarrowMarian A Ackun-Farmmer, Hanan Alwaseem, Michele Counts, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 16, 2021
Reduction of leukemic burden via bone-targeted nanoparticle delivery of an inhibitor of C-chemokine (C-C motif) ligand 3 (CCL3) signalingMarian A Ackun-Farmmer, Celia A Soto, Maggie L Lesch, et al.
ACS Nano|November 9, 2024
Engineered Immune Constructs Alter Antigen-Specific Immune Tolerance and Confer Durable Protection in Myelin-Driven AutoimmunityMarian A Ackun-Farmmer, Marina Willson Shirkey, Robert S Oakes, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2025
Local control of T cell fate in lymph nodes safely and durably reverses myelin-driven autoimmunitySenta M Kapnick, Emily A Gosselin, Shannon J Tsai, et al.
Pageof 1